$OVID - OVID Therapeutics - $2.08 Retest & Breakout - $2.60PTNASDAQ:OVID broke out in the Pre-Market, hitting $2.41, breaking through the $2.08 Levels of Resistance. We were looking for support above that $2.08 but see consolidation to that Lower Suport Trend, which we expect a continuation through the $2.08 to our $2.60 PT and Retest Expectations.
This comes after OVID reported Positive Topline Data on it's OV329 for Drug Resistant Epliepsies.
